{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:45:21Z","timestamp":1790383521273,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":478,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015237","name":"The Medicines Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bristol-Myers Squibb\/Sanofi-Aventis"},{"name":"Merck"},{"name":"Eli Lilly"},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca"},{"name":"Bristol-Myers Squibb"},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"name":"KAI Pharmaceuticals"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"sanofi-aventis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Schering-Plough Corporation"},{"name":"Orexigen"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.jacc.2011.12.045","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T19:37:07Z","timestamp":1337024227000},"page":"1861-1869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Temporal Trends in and Factors Associated With Bleeding Complications Among Patients Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"59","author":[{"given":"Sumeet","family":"Subherwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Messenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph G.","family":"Brindis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy N.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Senter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd W.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Marso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2011.12.045_bib1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.12.045_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/CIRCINTERVENTIONS.108.846741","article-title":"Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry","volume":"2","author":"Mehta","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2011.12.045_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/eurheartj\/ehm019","article-title":"Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes","volume":"28","author":"Rao","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2011.12.045_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ahj.2007.10.014","article-title":"Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes","volume":"155","author":"Rao","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2011.12.045_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.292.13.1555","article-title":"Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes","volume":"292","author":"Rao","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.12.045_bib6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.amjcard.2004.07.089","article-title":"Comparison of transradial and transfemoral approaches for coronary angiography and angioplasty in octogenarians (the OCTOPLUS study)","volume":"94","author":"Louvard","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2011.12.045_bib7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/hrt.2008.150714","article-title":"Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study","volume":"95","author":"Pristipino","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2011.12.045_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ahj.2006.12.014","article-title":"A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices","volume":"153","author":"Arora","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2011.12.045_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCINTERVENTIONS.109.896704","article-title":"Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial","volume":"3","author":"Sanborn","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2011.12.045_bib10","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1001\/jama.2010.708","article-title":"Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention","volume":"303","author":"Marso","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.12.045_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4244\/EIJV6I2A33","article-title":"The impact of bivalirudin on percutaneous coronary intervention-related bleeding","volume":"6","author":"Lindsey","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2011.12.045_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.12.045_bib13","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.12.045_bib14","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.12.045_bib15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ahj.2010.05.036","article-title":"Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes","volume":"160","author":"Elbarouni","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2011.12.045_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jacc.2010.05.008","article-title":"Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention","volume":"56","author":"Roe","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.12.045_bib17","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/S0735-1097(01)01372-9","article-title":"The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository","volume":"37","author":"Brindis","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.12.045_bib18","first-page":"459","article-title":"The American College of Cardiology National Database: progress and challenges","volume":"29","author":"Weintraub","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.12.045_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2011.12.045_bib21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(00)05059-5","article-title":"Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb\/IIIa inhibition: the GUSTO V randomised trial","volume":"357","author":"Topol","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2011.12.045_bib22","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","article-title":"What's the relative risk?","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.12.045_bib23","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","article-title":"Current role of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes","volume":"284","author":"Bhatt","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.12.045_bib24","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ahj.2010.08.008","article-title":"Changes in glycoprotein IIb\/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA guidelines (CRUSADE) initiative","volume":"160","author":"Mudrick","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2011.12.045_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1540-8183.2008.00351.x","article-title":"Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications","volume":"21","author":"Fitts","year":"2008","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jacc.2011.12.045_bib26","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2011.12.045_bib27","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/CIRCULATIONAHA.107.694273","article-title":"Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?","volume":"116","author":"Spencer","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.12.045_bib28","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(11)60404-2","article-title":"Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial","volume":"377","author":"Jolly","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2011.12.045_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.291.3.350","article-title":"Arterial puncture closing devices compared with standard manual compression after cardiac catheterization","volume":"291","author":"Koreny","year":"2004","journal-title":"JAMA"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712009400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712009400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:51:19Z","timestamp":1760014279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109712009400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":28,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0735109712009400"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2011.12.045","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal Trends in and Factors Associated With Bleeding Complications Among Patients Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2011.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}